Executive Director, US HCP Marketing - CIDP Indication Lead

## Executive Director, US HCP Marketing - CIDP Indication Lead Apply:
United States - Remote:
Full time:
Posted Today:
REQ-4538
* Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multi-dimensional expansion to reach more patients through a rich pipeline of differentiated assets, led by VYVGART, our first-in-class neonatal Fc receptor blocker approved for the treatment of gMG, and with the potential to treat patients across dozens of severe autoimmune diseases.
** We are building a new kind of biotech company, one that maintains its roots as a science-based start-up and pushes our commitment to innovate across all corners of our business. We strive to inspire and grow our company, our partnerships, our science, and our people, because when we do, we deliver more for patients.
* argenx US commercial team is looking for an Executive Director, US HCP Marketing for our CIDP Indication. The Executive Director will be a senior commercial leader accountable for maximizing growth of VYVGART Hytrulo in CIDP while strategically preparing for and integrating the launch of Empasiprubart for the treatment of CIDP, within a multi-asset therapeutic franchise.

You are accountable for leading the HCP commercial strategy, customer engagement model, and coordinated execution for the CIDP indication within our Neurology HCP Marketing community. This position will report to Neurology Marketing Community Lead, US HCP Experience.

You will partner closely with the Vice President, HCP Experience; HCP Marketing Indication and Brand Leads;
Field Leadership;
Thought Leader Liaisons;
Market Access;
Medical Affairs;
Patient Experience;
Digital;
Insights; and other cross-community partners to develop and execute integrated HCP engagement strategies that support business performance, launch readiness, and a consistent customer experience across the Neurology portfolio.
*
* Roles and Responsibilities:

*** Lead the HCP promotional strategy and execution to maximize growth for VYVGART Hytrulo in Chronic inflammatory demyelinating polyneuropathy (CIDP)
* Monitor portfolio performance, market dynamics, customer feedback, and engagement data to identify opportunities to optimize CIDP strategy, priorities, and execution.
* Collaborate with Global ICT and cross-functional partners to define the dual-asset strategy and co-positioning framework to ensure upcoming Empasiprubart launch in CIDP enhances franchise value.
* Develop a franchise-level value narrative that clarifies differentiation between two brands for CIDP while reinforcing complementary strengths.
* Lead HCP disease awareness and unbranded education strategies to shape the management of CIDP and elevate unmet needs.
* Ensure field teams have the messages, tools, training, and customer context needed to effectively engage HCPs across customer segments.
* Co-create evidence generation priorities in partnership with Medical and Development to support long-term differentiation.
* Anticipate competitive shifts and adapt ecosystem strategy accordingly.
* Serve as a core strategic voice for the HCP customer within the CIDP Indication Strategy Team.
* Provide clear direction, prioritization, and performance expectations for CIDP work streams and cross-community initiatives.
* Model enterprise mindset, cross-functional influence, and disciplined prioritization.
* Provide executive-ready strategic recommendations supported by analytics and scenario modeling.
* Partner with the Customer Engagement & Experience Community Lead to ensure Neurology HCP engagement reflects enterprise experience standards, journey design principles, voice of customer, and consistent engagement practices.
* Lead, coach, and develop…